Skip to main content
Log in

Neuropsychiatric manifestations of systemic lupus erythematosus: The value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

In an attempt to find a serological marker for neuropsychiatric manifestations (NPM) of SLE, sera from 66 patients (classified in three groups, according to their NPM — defined, probable and without NPM) were analysed by ELISA for IgG and IgM anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. A strong correlation was found between IgM antigangliosides and antigalactocerebrosides antibodies and NPM, but not with IgG class. IgM and IgG antibodies anticardiolipin were not correlated with NPM in this study. Both IgM antigangliosides and antigalactocerebrosides antibodies disappeared in seven patients with definite but clinically inactive NPM. The analysis of these autoantibodies showed an important role predictive for NPM in SLE; the negative test decreases the chance of the NPM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abel, T., Gladman, D.P., Urowitz, M.B. Neuropsychiatric lupus. J Rheumatol 1980, 7, 325.

    PubMed  Google Scholar 

  2. Dubois, E.L., Tuffanelli, D.E. Clinical manifestations of systemic lupus erythematosus. J Am Med Assoc 1964, 190, 104.

    Google Scholar 

  3. Ellis, S.G., Verity, A.M. Central nervous system involvement in systemic lupus erythematosus. A review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 1975, 8, 212.

    Google Scholar 

  4. Estes, D., Christian, C.L. The natural history of systemic lupus erythematosus studied by prospective analyses. Medicine 1971, 50, 85.

    PubMed  Google Scholar 

  5. Grigor, R., Edmonds, J., Leukonia, R., et al: Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis, 1978, 37, 121.

    PubMed  Google Scholar 

  6. Johnson, R.T., Richardson, E.P. The neurologic manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 1968, 47, 337.

    PubMed  Google Scholar 

  7. Lee, P., Urowitz, M.B., Bookman, A.A., et al: Systemic lupus erythematosus. Q J Med 1977, 46, 1.

    PubMed  Google Scholar 

  8. Steinman, C.R. Circulating DNA in systemic lupus erythematosus. Association with central nervous system involvement and systemic vasculitis. Am J Med 1979, 67, 429.

    PubMed  Google Scholar 

  9. Winfield, J.B., Brunner, C.M., Koffler, D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum 1978, 21, 289.

    PubMed  Google Scholar 

  10. Wilson, H.A., Winfield, J.B., Lahita, R.G., et al: Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 1979, 22, 458.

    PubMed  Google Scholar 

  11. Golombeck, S.J., Graus, F., Elkon, K.B. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 1986, 29, 1090.

    PubMed  Google Scholar 

  12. Bluestein, H.G., Zvaifler, N.J. Brain-reactive lymphocitotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976, 57, 509.

    PubMed  Google Scholar 

  13. Bresnihan, B., Oliver, M., Grigor, R., Hughes, G.R.V. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol 1977, 30, 333.

    PubMed  Google Scholar 

  14. Quismorio, F.P., Friou, G.J. Antibodies reactive with neurons in SLE patients with neuropsychiatric manifestations. Int Arch Allergy Appl Immunol, 1972, 43, 740.

    PubMed  Google Scholar 

  15. Bluestein, H.G. Heterogenous neurocytotoxic antibodies in systemic lupus erythematosus. Clin Exp Immunol, 1979, 35, 210.

    PubMed  Google Scholar 

  16. Bluestein, H.G., Williams, G.W., Steinberg, A.D. Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981, 70, 240.

    PubMed  Google Scholar 

  17. Bresnihan, B., Oliver, M., Williams, B., et al. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum 1979, 22, 313.

    PubMed  Google Scholar 

  18. Golub, E.S. III Brain-associated erythrocyte antigen: An antigen shared by brain and erythrocytes. Exp Hematol 1973, 1, 105.

    PubMed  Google Scholar 

  19. Bonfa, E., Golombek, S.J., Kaufman, L.D., et al. Association between lupus psychosis and anti-ribomosal P protein antibodies. N Engl J Med 1987, 317, 265.

    PubMed  Google Scholar 

  20. Firlan, B.G., Howard, M.A., Radford, N. Possible relationship between the lupus inhibitor and recurrent abortion in young women. Lancet 1980, 11, 366.

    Google Scholar 

  21. Harris, E.N., Body, M.L., Young, C.G.M., et al. Anticardiolipin antibodies: detection by radio-immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 26, 1211.

    Google Scholar 

  22. Hughes, G.R.V. Central nervous system lupus-diagnosis and treatment. J Rheumatol 1980, 7, 405.

    PubMed  Google Scholar 

  23. Laurell, A.B., Nilsson, I.M. Hypergammaglobulinema, circulating antigoagulant, and biologic false positive Wasserman. J Lab Clin Med 1957, 49, 694.

    PubMed  Google Scholar 

  24. Lechner, K. Acquired inhibitors in nonhaemophilic patient. Haemostasis, 1974, 3, 65.

    PubMed  Google Scholar 

  25. Scheider, M.A., Nachman, R.I., Jaffe, E.A., Coleman, M. A clinical study of lupus anticoagulant. Blood 1976, 48, 499.

    PubMed  Google Scholar 

  26. Wilson, A., Hughes, G.R.V. Aetiology of Jamaican neuropathy. Lancet 1975, 1, 240.

    PubMed  Google Scholar 

  27. Hirano, T., Hashimoto, H., Shiokawa, Y., et al: Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest 1980, 66, 1437.

    PubMed  Google Scholar 

  28. Endo, T., Scott, D.D., Stewart, S.S., et al. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE Adv Exp Med Biol 1984, 174, 455.

    Google Scholar 

  29. Tan, E.M., Cohen, A.S., Fries, J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25, 1271.

    PubMed  Google Scholar 

  30. How, A., Dent, P.B., Liao, S.K., et al. Antineuronal antibodies in neuropsychiatric systemic erythematosus. Arthritis Rheum 1985, 28, 789.

    PubMed  Google Scholar 

  31. Friou, G.L., Finch, S.C., Detre, K.D. Interaction of nuclei and globulin from lupus erythematosus serum demonstrated with fluorescent antibody. J Immunol 1958, 80, 324.

    PubMed  Google Scholar 

  32. Parker, M.D., Kerby, G.P. Combined titer and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases. Ann Rheum Dis 1974, 33, 465.

    PubMed  Google Scholar 

  33. Singer, J.M., Plotz, C.M. Slide latex fixation test. JAMA, 1958, 168, 180.

    Google Scholar 

  34. Growe, W., Kushner, I. An immunofluorescent method using Crithidia lucilliae to detect antibodies to double-stranded DNA. Arthritis Rheum 1977, 20, 881.

    Google Scholar 

  35. Sharp, G.C., Irvin, W.S. Hemagglutinating antibody to DNA and to the extractable nuclear antigen in systemic lupus erythematosus. Arthritis Rheum 1968, 11, 116.

    Google Scholar 

  36. Tan, E.M., Kunkel, H. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966, 96, 464.

    PubMed  Google Scholar 

  37. Canoso, R.T., Oliveira, R.M. Chlorpromazyne-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis. Am J Hematol 1988, 27, 272.

    PubMed  Google Scholar 

  38. Rapport, M.M., Graf, L., Skipski, V.P. Cytolipin H, a pure lipid hapten isolated from human carcinome. Nature 1958, 181, 1803.

    PubMed  Google Scholar 

  39. Karpiak, S.E., Graf, L., Rapport, M.M. Antiserum to brain gangliosides produces recurrent epilepti form activity. Science (Wash DC), 1976, 194, 735.

    Google Scholar 

  40. Sergott, R.C., Brown, M.J., Silberberg, D.H., et al. Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Science, 1984, 64, 297.

    Google Scholar 

  41. Tsukada, N., Koh, C.S., Yanagiswa, N., et al. Peripheral nervous tissue injury induced by galactocerebrosides and galactocerebrosides immune complexes. Acta Neuropathol (Berl), 1985, 66, 274.

    Google Scholar 

  42. Sotskii, O.P., et al. Cerebrosides as one of the factors regulating the functional state of the blood vascular wall system. Biull Eksp Biol Med, 1984, 97, 387. (Eng. abst Russ).

    PubMed  Google Scholar 

  43. Yokoyama, M., Trams, E.G., Brady, R.O. Sphingolipid antibodies in sera of animals and patients with central nervous system lesions. Proc Soc Exp Biol Med 1962, 111, 350.

    PubMed  Google Scholar 

  44. Arnon, R., Crisp, E., Kelley, R., Ellison, G.W., Myers, L.W., Tourtelleto, W.W. Anti-gangliode antibodies in multiple sclerosis. J Neurol Sci 1980, 46, 179.

    PubMed  Google Scholar 

  45. Endo, T., Scott, D.D., Stewart, S.S., Kundu, S.K., Marcus, D.M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. Adv Exp Med Biol 1984, 174, 455.

    PubMed  Google Scholar 

  46. Hirsch, H.E., Parks, M.E. Serological reactions against glycolipid sensitised liposomes in multiple sclerosis. Nature 1976, 264, 785.

    PubMed  Google Scholar 

  47. Fulford, K.W.M., Catterall, R.D., Delhanty, J.J., et al. A collagen disorder of the nervous system presenting as multiple sclerosis. Brain 1972, 95, 373.

    PubMed  Google Scholar 

  48. Holmes, F.F., Stubbs, D.N., Larsen, W.E. Systemic lupus erythematosus and multiple sclerosis in identical twins. Arch Intern Med 1967, 119, 302.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costallat, L.T.L., de Oliveira, R.M., Santiago, M.B. et al. Neuropsychiatric manifestations of systemic lupus erythematosus: The value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin Rheumatol 9, 489–497 (1990). https://doi.org/10.1007/BF02030510

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02030510

Key words

Navigation